Noxopharm Ltd Total Liabilities

Latest as of December 2025: AU$5.88 Million AUD ≈ $4.16 Million USD

Noxopharm Ltd total liabilities. Based on the latest financial reports, Noxopharm Ltd (NOX) has total liabilities worth AU$5.88 Million AUD (≈ $4.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Noxopharm Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Noxopharm Ltd (2016–2025)

Total liabilities of Noxopharm Ltd from 2016 to 2025. This chart illustrates how Noxopharm Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Noxopharm Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Noxopharm Ltd Competitors by Total Liabilities

The table below lists competitors of Noxopharm Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
NGX Ltd AU:NGX	Australia	AU$257.64K
PowerBank Corporation NEO:PBK	Canada	CA$105.51 Million
NGS Group AB (publ) ST:NGS	Sweden	Skr55.14 Million
WISDOM ED.INTL.HLD.HD-01 F:5Q4	Germany	€547.57 Million
Elcora Advanced Materials Corp V:ERA	Canada	CA$3.09 Million
SWS Capital Bhd KLSE:7186	Malaysia	RM38.01 Million
BARRAMUNDI GROUP PTE. LTD F:95Z	Germany	€22.39 Million
Educational Development Corporation NASDAQ:EDUC	USA	$11.48 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Noxopharm Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Noxopharm Ltd balance sheet assets.

Liquidity & Leverage Metrics

Noxopharm Ltd Total Liabilities Ratios Explained

Noxopharm Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.02	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-5.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Noxopharm Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Noxopharm Ltd (2016–2025)

The table below shows the annual total liabilities of Noxopharm Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.89 Million ≈ $2.75 Million	+201.99%
2024-06-30	AU$1.29 Million ≈ $911.78K	+22.12%
2023-06-30	AU$1.06 Million ≈ $746.61K	-57.38%
2022-06-30	AU$2.48 Million ≈ $1.75 Million	-65.02%
2021-06-30	AU$7.08 Million ≈ $5.01 Million	-1.63%
2020-06-30	AU$7.19 Million ≈ $5.09 Million	+25.10%
2019-06-30	AU$5.75 Million ≈ $4.07 Million	+30.66%
2018-06-30	AU$4.40 Million ≈ $3.11 Million	+1119.07%
2017-06-30	AU$361.04K ≈ $255.46K	+37.95%
2016-06-30	AU$261.72K ≈ $185.18K	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$7.61 Million

AU$10.75 Million AUD

Market Cap Rank

#27575 Global

#1351 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.04 - AU$0.10

All Time High

AU$1.58